Hua Medicine has announced the first innovative diabetes drug, Dozaglietin. (Dorzagliatin's NDA application was accepted by the National Medical Products Administration's (NMPA) Center for...
To mark May's Healthy Vision Month, Focus on Diabetes ™ was launched - a multi-year initiative bringing together the American Diabetes Association® (ADA) and...